论文部分内容阅读
目的研究甘精胰岛素联合瑞格列奈片对老年2型糖尿病(T2DM)患者血糖指标及低血糖发生率的影响。方法选取我院2014年1月到2016年1月收治的134例老年T2DM患者,随机分为观察组和对照组,各67例患者。观察组采用甘精胰岛素联合瑞格列奈片进行治疗,对照组采用诺和灵进行治疗,观察并比较两组患者治疗效果。结果观察组治疗后血糖显著低于对照组,胰岛素用量、低血糖例数均少于对照组,差异均有统计学意义(均P<0.05)。结论使用甘精胰岛素联合瑞格列奈片能有效控制老年糖尿病患者的血糖,降低临床低血糖率。
Objective To investigate the effects of glargine and repaglinide on the incidence of hypoglycemia and the incidence of hypoglycaemia in elderly patients with type 2 diabetes mellitus (T2DM). Methods A total of 134 elderly patients with T2DM admitted to our hospital from January 2014 to January 2016 were randomly divided into observation group and control group, each with 67 patients. The observation group was treated with insulin glargine combined with repaglinide, and the control group was treated with noradrenaline. The therapeutic effect was observed and compared between the two groups. Results After treatment, the blood glucose of the observation group was significantly lower than that of the control group. The amount of insulin and the number of hypoglycemia were all less in the observation group than in the control group (all P <0.05). Conclusion The combination of insulin glargine and repaglinide can effectively control the blood glucose of elderly diabetic patients and reduce the clinical hypoglycemic rate.